
The latest issue of our groundbreaking print magazine is out now. Once again, we’ve packed the pages with untold stories from the worlds of cannabis, psychedelics and culture. Grab your copy today: leafie.co.uk/products/the-le…

Cannabis, psychedelics and culture for the curious.

The latest issue of our groundbreaking print magazine is out now. Once again, we’ve packed the pages with untold stories from the worlds of cannabis, psychedelics and culture. Grab your copy today: leafie.co.uk/products/the-le…

New research involving almost 36,000 people has found no significant change in cannabis consumption following Germany's move to partially legalise the drug in 2024. leafie.co.uk/cannabis/no-ris…

A review of 28 scientific studies has found that the familiar indica and sativa labels don’t reliably predict a cannabis strain’s effects or chemical composition. leafie.co.uk/cannabis/indica…

Ten synthetic cannabinoids and two natural, non-intoxicating cannabinoids are set to be banned in the UK in an update to the Misuse of Drugs Act. leafie.co.uk/news/uk-thca-hh…

One of the UK's best-known high street retailers, Boots, has launched a medical cannabis service for patients living with chronic pain, anxiety and insomnia. SureLeaf will offer flower and oil, but will only accept patients aged 25 and over. leafie.co.uk/cannabis/boots-…

Latest ONS figures show the first fall in drug poisoning fatalities in England and Wales for more than a decade. But with thousands of lives still being lost, campaigners say we should be doing much more to prevent drug deaths. leafie.co.uk/health/britains…

A survey of male medical cannabis patients found that 82% of those whose conditions had affected their mental well-being reported an improvement after starting treatment. Many reported living with symptoms for more than a decade. leafie.co.uk/cannabis/men-re…

Eight years after medical cannabis was legalised in the UK, almost all prescribing still happens privately. @CuraleafClinic's Dr Simon Erridge examines the growing evidence and makes the case for publicly funded trials to support wider access. #ad leafie.co.uk/cannabis/eight-…

From French pharmacies to psychiatric research, ibogaine and psilocybin have a pharmaceutical history that predates today’s Wall Street hype. As investor excitement grows, questions about ownership and who earns the profits are becoming harder to ignore. leafie.co.uk/psychedelics/bi…

Bedrocan says ‘substantial’ stocks of Bedrolite remain in the Netherlands, but their release depends on bankruptcy negotiations and Dutch regulatory approval. Meanwhile, families whose children rely on the medicine face uncertainty over future supplies. leafie.co.uk/cannabis/britis…

Adults taking part in a Swiss pilot allowing pharmacies to sell recreational cannabis reported small improvements in mental health, with the largest reduction in problematic use among those at highest risk. leafie.co.uk/news/legal-cann…

Harm reduction charity The Loop will open Birmingham’s first community drug-checking service, offering free substance analysis and anonymous health consultations at two locations thanks to funding from the City Council. leafie.co.uk/health/free-dru…

Psilocybin, the psychedelic compound found in magic mushrooms, helped build new connections between brain cells and reduce further losses caused by prolonged stress in mice. leafie.co.uk/psychedelics/ps…

Almost a quarter of people who consumed cannabis in the previous year reported daily use, with regular consumption more common among older adults and people who smoke tobacco. leafie.co.uk/cannabis/1-2-mi…

New research suggests that increasing the amount of THC consumed produces diminishing increases in intoxication, challenging assumptions about the relationship between cannabis potency and its effects. leafie.co.uk/news/doubling-t…

Cannabis seeds and preserved human hair from a Siberian tomb offer what researchers describe as the earliest directly dated evidence of cannabis use for its intoxicating effects. leafie.co.uk/cannabis/people…